Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-71,590
Closed -$7.32M 170
2024
Q2
$7.32M Sell
71,590
-397,987
-85% -$38.8M 0.36% 81
2024
Q1
$41.6M Buy
469,577
+284,202
+153% +$23.6M 2.21% 8
2023
Q4
$16.9M Buy
185,375
+37,096
+25% +$2.98M 0.77% 42
2023
Q3
$11.6M Buy
+148,279
New +$12.7M 0.49% 64
2022
Q3
Sell
-48,768
Closed -$5.28M 174
2022
Q2
$5.28M Buy
48,768
+233
+0.5% +$28.2K 0.37% 79
2022
Q1
$5M Buy
+48,535
New +$6.45M 0.53% 60

Other funds holding MMM

Invenomic Capital Management's MMM Position: Q3 2024 in Review

Invenomic Capital Management sold out of 3M (MMM) in Q3 2024, closing a stake of 71,590 shares — an estimated $7.32M sold.

Invenomic Capital Management first reported a position in MMM in Q1 2022 and held it in 6 quarters. The position peaked at $41.6M in Q1 2024. 2,084 funds tracked by Wall St. Rank hold MMM as of Q3 2024.

  • Invenomic Capital Management reported no remaining 3M position as of Q3 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 71,590 3M shares in Q3 2024, an estimated $7.32M.
  • Invenomic Capital Management first reported a position in 3M in Q1 2022 and held it in 6 quarters.
  • Invenomic Capital Management's 3M position peaked at $41.6M in Q1 2024.
  • 2,084 funds tracked by Wall St. Rank held 3M as of Q3 2024.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.